Response to letter to the editor "the impact of bisphosphonates on mortality and cardiovascular risk among osteoporosis patients after cardiovascular disease".

Wu, Shu-Ting; Chen, Jung-Fu; Tsai, Chia-Jen

Wu, Shu-Ting; Chen, Jung-Fu; Tsai, Chia-Jen.

Afiliação

Wu ST; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Chen JF; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Tsai CJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. Electronic address: lkmann@cgmh.org.tw.

J Formos Med Assoc ; 120(11): 2046-2047, 2021 11.

Article em En | MEDLINE | ID: mdl-34049757

Assuntos

Conservadores da Densidade Óssea; Doenças Cardiovasculares; Osteoporose; Conservadores da Densidade Óssea/uso terapêutico; Doenças Cardiovasculares/epidemiologia; Difosfonatos/uso terapêutico; Fatores de Risco de Doenças Cardíacas; Humanos; Osteoporose/tratamento farmacológico; Fatores de Risco

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Doenças Cardiovasculares / Conservadores da Densidade Óssea Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google